Afatinib

Artikelnummer	Größe	Manual	Lieferzeit	Preis
LKT-A2077.5	5 mg	-	3 - 8 Werktage*	167,00 €
LKT-A2077.10	10 mg	-	3 - 8 Werktage*	257,00 €
LKT-A2077.25	25 mg	-	3 - 8 Werktage*	449,00 €
LKT-A2077.100	100 mg	-	3 - 8 Werktage*	1.283,00 €

Bei Fragen nutzen Sie gerne unser Kontaktformular.
Bestellen Sie auch per E-Mail: info@biomol.com
Größere Menge gewünscht? Bulk-Anfrage

Afatanib is an anticancer chemotherapeutic compound that has been approved to treat advanced lung... mehr

Menü schließen

Produktinformationen "Afatinib"

Afatanib is an anticancer chemotherapeutic compound that has been approved to treat advanced lung cancers such as non-small cell lung cancer (NSCLC) and is in clinical trials as a potential treatment for other advanced solid tumors such as breast cancer and colorectal cancer. Afatanib exerts its anticancer activity through inhibition of EGFR and EGRF2 (HER2/ErbB2). In vivo, afatanib downregulates expression of HER2, increasing apoptosis and decreasing tumor size.

Schlagworte:	BIBW 2992
Hersteller:	LKT Laboratories
Hersteller-Nr:	A2077

Eigenschaften

Anwendung:	EGFR / ErbB2 inhibitor
MW:	485.94 D
Reinheit:	>98%
Format:	Solid

Datenbank Information

KEGG ID :

K04361 | Passende Produkte

Handhabung & Sicherheit

Lagerung:	+4°C
Versand:	+4°C (International: +4°C)
Signalwort:	Danger
GHS-Piktogramme:
H-Sätze:	H300, H315, H318, H361, H373
P-Sätze:	P201, P202, P260, P264, P270, P280, P281, P314, P321, P330, P301+P310, P302+P352, P305+P351+P338, P308+P313, P332+P313, P337+P313, P362+P364, P405, P501